Jose Luis Pablos
Overview
Explore the profile of Jose Luis Pablos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
716
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Candel F, Barreiro P, Salavert M, Cabello A, Fernandez-Ruiz M, Perez-Segura P, et al.
Viruses
. 2023 Jul;
15(7).
PMID: 37515137
The clinical evolution of patients infected with the Severe Acute Respiratory Coronavirus type 2 (SARS-CoV-2) depends on the complex interplay between viral and host factors. The evolution to less aggressive...
2.
San-Juan R, Fernandez-Ruiz M, Lopez-Medrano F, Carretero O, Lalueza A, Maestro de la Calle G, et al.
Int J Infect Dis
. 2022 Jan;
117:56-64.
PMID: 35081417
Background: Controversy remains about the efficacy of tocilizumab (TCZ) for the treatment of severe COVID-19. We aimed to analyze the profile of TCZ-respondent patients. Methods: We retrospectively analyzed a cohort...
3.
Retuerto M, Trujillo E, Valero C, Fernandez-Espartero C, Soleto C, Garcia-Valle A, et al.
Clin Exp Rheumatol
. 2021 May;
39(3):453-455.
PMID: 33938793
Objectives: Different Jak inhibitors (jakinibs) have shown efficacy in rheumatoid arthritis (RA), but in a significant proportion of patients, an insufficient response leads to therapy withdrawal. We describe the efficacy...
4.
de la Calle C, Lopez-Medrano F, Pablos J, Lora-Tamayo J, Maestro-de la Calle G, Sanchez-Fernandez M, et al.
Int J Infect Dis
. 2021 Feb;
105:319-325.
PMID: 33592340
Objectives: A subgroup of patients with SARS-CoV-2 infection was thought to have developed cytokine release syndrome and were treated with tocilizumab; however, a significant percentage of patients evolved. This study...
5.
Freites-Nunez D, Baillet A, Rodriguez-Rodriguez L, Nguyen M, Gonzalez I, Pablos J, et al.
Trials
. 2020 Sep;
21(1):755.
PMID: 32867830
Background: Rheumatoid arthritis (RA) is one of the leading chronic inflammatory rheumatism. First-line therapy with synthetic disease-modifying antirheumatic drugs (sDMARD) is insufficiently effective in 40% of cases and these patients...
6.
Fernandez-Ruiz M, Lopez-Medrano F, Perez-Jacoiste Asin M, Maestro de la Calle G, Bueno H, Caro-Teller J, et al.
J Med Virol
. 2020 Jul;
93(2):831-842.
PMID: 32672860
Coronavirus disease 2019 (COVID-19) can lead to a massive cytokine release. The use of the anti-interleukin-6 receptor monoclonal antibody tocilizumab (TCZ) has been proposed in this hyperinflammatory phase, although supporting...
7.
Pablos J, Navarro F, Blanco F, Roman-Ivorra J, Alonso A, Martin Mola E, et al.
Clin Exp Rheumatol
. 2020 May;
38(3):585.
PMID: 32456768
No abstract available.
8.
Diaz R, Galina C, Aranda E, Aceves L, Sanchez J, Pablos J
Anim Reprod
. 2020 May;
17(1):e20190074.
PMID: 32399065
The effect of climatic factors on ovarian activity and reproductive behavior (RB) was evaluated in 46 cows kept under grazing conditions. Temperature-humidity index (THI) was used as an indicator of...
9.
Ruiz de Morales J, Puig L, Dauden E, Canete J, Pablos J, Olveira Martin A, et al.
Autoimmun Rev
. 2019 Nov;
19(1):102429.
PMID: 31734402
Interleukin 17 (IL-17) is a proinflammatory cytokine that has been the focus of intensive research because of its crucial role in the pathogenesis of different diseases across many medical specialties....
10.
Acebes C, Andreu J, Balsa A, Batlle E, De Toro-Santos J, Garcia Llorente F, et al.
Clin Exp Rheumatol
. 2019 Oct;
38(1):82-87.
PMID: 31573477
Objectives: To explore the remission concept in rheumatoid arthritis (RA) and the implications of the existing definitions when applied to clinical practice among rheumatologists with different profiles. Methods: A qualitative...